Literature DB >> 10960522

Differential expression of the duffy antigen receptor for chemokines according to RBC age and FY genotype.

I J Woolley1, K A Hotmire, R M Sramkoski, P A Zimmerman, J W Kazura.   

Abstract

BACKGROUND: The Duffy (Fy) blood group (also known as Duffy antigen receptor for chemokines, or DARC) may be involved in regulation of the level of circulating proinflammatory chemokines, and it is an obligatory receptor on RBCs for the human malaria parasite Plasmodium vivax. STUDY DESIGN AND METHODS: Because quantification of Fy expression by using RBCs of various ages will not detect acute changes associated with inflammatory states, and because P. vivax exclusively invades reticulocytes, a flow cytometric method was developed to measure the level of surface expression of Fy. Reticulocytes and mature RBCs from persons with different genotypes (GATA-1 T-->C promoter mutation at nt -46; FY*A and FY*B in the ORF) were used.
RESULTS: Expression of the Fy6 epitope, which is required for P. vivax invasion, was 49 +/- 19 percent higher on reticulocytes than on mature RBCs, regardless of donor genotype (p<0.0001). Fy6 levels were approximately 50 percent lower in persons who were heterozygous for the GATA-1 promoter mutation and were significantly lower on reticulocytes and mature RBCs of the FY*B/FY*B genotype than on those of the FY*A/FY*A or FY*A/FY*B genotype.
CONCLUSION: Fy has greater expression on reticulocytes than on mature RBCs in flow cytometry. This method may be useful in further studies of this antigen, such as characterization of reticulocytes and RBC phenotypes across populations, in response to chemokine regulation, and in the context of susceptibility to P. vivax and other parasites.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10960522     DOI: 10.1046/j.1537-2995.2000.40080949.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  14 in total

Review 1.  Methodology and application of flow cytometry for investigation of human malaria parasites.

Authors:  Brian T Grimberg
Journal:  J Immunol Methods       Date:  2011-02-04       Impact factor: 2.303

2.  FY polymorphisms and vivax malaria in inhabitants of Amazonas State, Brazil.

Authors:  Sérgio Roberto Lopes Albuquerque; Francimary de Oliveira Cavalcante; Edalton Cesar Sanguino; Lucianna Tezza; Fernanda Chacon; Lilian Castilho; Maria Cristina dos Santos
Journal:  Parasitol Res       Date:  2010-02-17       Impact factor: 2.289

Review 3.  Red blood cell polymorphism and susceptibility to Plasmodium vivax.

Authors:  Peter A Zimmerman; Marcelo U Ferreira; Rosalind E Howes; Odile Mercereau-Puijalon
Journal:  Adv Parasitol       Date:  2013       Impact factor: 3.870

4.  Acquired antibody responses against Plasmodium vivax infection vary with host genotype for duffy antigen receptor for chemokines (DARC).

Authors:  Amanda Maestre; Carlos Muskus; Victoria Duque; Olga Agudelo; Pu Liu; Akihide Takagi; Francis B Ntumngia; John H Adams; Kim Lee Sim; Stephen L Hoffman; Giampietro Corradin; Ivan D Velez; Ruobing Wang
Journal:  PLoS One       Date:  2010-07-15       Impact factor: 3.240

5.  Plasmodium vivax blood-stage dynamics.

Authors:  F Ellis McKenzie; Geoffrey M Jeffery; William E Collins
Journal:  J Parasitol       Date:  2002-06       Impact factor: 1.276

6.  Age-structured red blood cell susceptibility and the dynamics of malaria infections.

Authors:  Philip G McQueen; F Ellis McKenzie
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-03       Impact factor: 11.205

7.  Analysis for genotyping Duffy blood group in inhabitants of Sudan, the fourth cataract of the Nile.

Authors:  Agnieszka Kempińska-Podhorodecka; Oktawian Knap; Arleta Drozd; Mariusz Kaczmarczyk; Miroslaw Parafiniuk; Milosz Parczewski; Andrzej Ciechanowicz
Journal:  Malar J       Date:  2012-04-17       Impact factor: 2.979

8.  Platelets kill circulating parasites of all major Plasmodium species in human malaria.

Authors:  Steven Kho; Bridget E Barber; Edison Johar; Benediktus Andries; Jeanne R Poespoprodjo; Enny Kenangalem; Kim A Piera; Anna Ehmann; Ric N Price; Timothy William; Tonia Woodberry; Simon Foote; Gabriela Minigo; Tsin W Yeo; Matthew J Grigg; Nicholas M Anstey; Brendan J McMorran
Journal:  Blood       Date:  2018-07-19       Impact factor: 25.476

9.  Correlation between Duffy blood group phenotype and breast cancer incidence.

Authors:  Xiao-Feng Liu; Lian-Fang Li; Zhou-Luo Ou; Rong Shen; Zhi-Min Shao
Journal:  BMC Cancer       Date:  2012-08-28       Impact factor: 4.430

10.  Duffy blood group gene polymorphisms among malaria vivax patients in four areas of the Brazilian Amazon region.

Authors:  Carlos E Cavasini; Luiz C de Mattos; Alvaro A R D'Almeida Couto; Vanja S C D'Almeida Couto; Yuri Gollino; Laurence J Moretti; Cláudia R Bonini-Domingos; Andréa R B Rossit; Lilian Castilho; Ricardo L D Machado
Journal:  Malar J       Date:  2007-12-19       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.